Between branded drug life cycle management and innovative generics (Part 1)
|Dr. Norbert Ettner|
has been working for more than 18 years in the interface of innovation management & IP, technology scouting, business development & licensing, alliances and M&A in healthcare and life science, being an industrial advisor for a private equity fund, too. Further, he gained experiences in investment and portfolio management of a startup life science venture capitalist. He studied chemistry, biochemistry and microbiology in Erlangen (Germany) where he received his PhD in biochemistry working one year at Wyeth Pharma´s Medical Research Division in New York.